InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
7
Disclosed sells
5
T+90 hit rate
29%
T+90 mean return
-22.1%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Hawkins James B, Director. Officer active across 4 companies, notably AUDIOEYE INC. In total, 68 reports have been logged. Breakdown: 7 buys · 5 sells. Total volume traded: €2.2m. History available since 8 July 2021. The latest transaction was filed on 20 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hawkins James B
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations68 total
90 shares@ US$220.92Common StockSEC:0000898243-26-000021:0
144 shares@ US$228.560.0009% mcap1.2% of flowCommon StockSEC:0000898243-26-000019:0
170 shares@ US$217.300.0010% mcap1.3% of flowCommon StockSEC:0000898243-26-000017:0
924 shares@ US$216.650.0058% mcap7.3% of flowCommon StockSEC:0000898243-26-000015:0
231 shares@ US$221.760.0014% mcap2.9% of flowCommon StockSEC:0000898243-26-000013:0
1,000 sharesCommon StockSEC:0000898243-26-000011:0
8,500 sharesCommon StockSEC:0000898243-26-000009:0
667 shares0Common StockSEC:0000898243-26-000007:0
14,000 shares@ US$5.90819.2% of flowCommon StockSEC:0000898243-26-000005:0
Canonical exit: 8 Jun 2026 (T+90)
667 shares0Common StockSEC:0000898243-26-000002:0
15 shares@ US$259.440.1% of flowCommon StockSEC:0000898243-25-000031:0
905 sharesCommon StockSEC:0000898243-25-000026:0
3,000 shares@ US$96.612540.5% of flowCommon StockSEC:0000898243-25-000024:0
1,197 sharesCommon StockSEC:0000898243-25-000022:0
2,000 shares@ US$11.602.9% of flowCommon StockSEC:0000898243-25-000020:0
Canonical exit: 18 Feb 2026 (T+90)
28 shares@ US$88.290.6% of flowCommon StockSEC:0000898243-25-000018:0
2,000 shares@ US$11.57482.9% of flowCommon StockSEC:0000898243-25-000013:0
Canonical exit: 15 Feb 2026 (T+90)
6,000 shares@ US$11.90339.3% of flowCommon StockSEC:0000898243-25-000011:0
Canonical exit: 11 Feb 2026 (T+90)
8,000 shares@ US$12.57513.2% of flowCommon StockSEC:0000898243-25-000009:0
Canonical exit: 9 Feb 2026 (T+90)
1,500 shares@ US$283.1516.6% of flowCommon StockSEC:0000898243-25-000008:0
667 shares0Common StockSEC:0000898243-25-000004:0
895 shares@ US$223.399.3% of flowCommon StockSEC:0001415889-25-022775:0
8,000 shares@ US$10.94514.7% of flowCommon StockSEC:0001415889-25-022368:0
Canonical exit: 16 Nov 2025 (T+90)
144 shares@ US$236.051.7% of flowCommon StockSEC:0001415889-25-022117:0
170 shares@ US$226.082.0% of flowCommon StockSEC:0001415889-25-020668:0
25 of 68 declarations
About Hawkins James B
James B. Hawkins is a Director at AUDIOEYE INC, Iradimed CORP and OSI Systems INC, and President and CEO at Natus Medical INC. The block shows 64 filings in total, with the recent sampled filings covering buys of EUR 488500 and sells of EUR 1685885 between 2016-01-06 and 2026-07-07, and the modal transaction nature is Attribution.
